{"meta":{"query_hash":"416724d61cad","filters":{"venue":"Drug Target Insights"},"cohort_total":10,"direct_labels_cover":0,"predictions_cover":10,"exported":10,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/416724d61cad","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drug+Target+Insights"},"results":[{"id":"W1496935185","doi":"10.4137/dti.s447","title":"Therapies to Increase ApoA-I and HDL-Cholesterol Levels","year":2008,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Reverse cholesterol transport; Cholesterol; Medicine; Internal medicine; Endocrinology; Lipoprotein; High-density lipoprotein; Excretion; Endogeny","score_opus":0.019949095845854983,"score_gpt":0.2353904733805925,"score_spread":0.21544137753473752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1496935185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98815864,0.0055081923,0.00024180421,0.0007606765,0.00017807542,0.0006659467,0.000015774547,0.0001414245,0.0043294644],"genre_scores_gemma":[0.99100965,0.00024087058,0.0024738875,0.0026697794,0.00046500965,0.00006527589,0.000024812318,0.000047983318,0.0030027279],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998478,0.00010155465,0.0002486183,0.0004163066,0.00042443044,0.00033108992],"domain_scores_gemma":[0.99883497,0.00004629552,0.00004519668,0.0005482034,0.00010738096,0.0004179421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019334683,0.00025677515,0.00054934825,0.00019142225,0.00020168486,0.000031464057,0.000108567074,0.00009102671,0.00009413783],"category_scores_gemma":[0.00008335349,0.00020168531,0.0001869,0.00019803316,0.00012585698,0.00017185579,0.00007330484,0.00019625566,0.00018242968],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001178137,0.0020492482,0.035491064,0.0008413044,0.004336245,0.0030816628,0.12326154,0.00009300251,0.012567514,0.0011854073,0.06811941,0.74779546],"study_design_scores_gemma":[0.0029182532,0.00022748655,0.36759406,0.00013301695,0.00012949792,0.00023174012,0.00034680538,0.00003804545,0.020667732,0.0006658428,0.6065875,0.00045995635],"about_ca_topic_score_codex":0.003049405,"about_ca_topic_score_gemma":0.00024981727,"teacher_disagreement_score":0.7473355,"about_ca_system_score_codex":0.00003532953,"about_ca_system_score_gemma":0.00007304608,"threshold_uncertainty_score":0.82244885},"labels":[],"label_agreement":null},{"id":"W1546961109","doi":"10.4137/dti.s378","title":"Recent Advancements in Targeted Delivery of Therapeutic Molecules in Neurodegenerative Disease–-Spinocerebellar Ataxia–-Opportunities and Challenges","year":2008,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Faculty of Medicine, McGill University; McGill University","keywords":"Medicine; Spinocerebellar ataxia; Disease; Gene silencing; Bioinformatics; Genetic enhancement; Ataxia; Drug discovery; Nanocarriers; Computational biology; Drug; Neuroscience; Gene; Biology; Pharmacology; Genetics; Pathology; Psychiatry","score_opus":0.04820452856902558,"score_gpt":0.23936255618856658,"score_spread":0.191158027619541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1546961109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86599106,0.1331246,0.000021634807,0.00023324092,0.00008250815,0.00017464849,0.000027692025,0.00000570011,0.00033893427],"genre_scores_gemma":[0.75603163,0.24326263,0.00012213492,0.00025196068,0.000029367895,0.000023047967,0.00012756634,0.000014851741,0.00013678153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987534,0.00015045254,0.00031901282,0.00040278863,0.00014698718,0.00022733226],"domain_scores_gemma":[0.9994453,0.000012782551,0.0000972979,0.00025469836,0.00010229132,0.00008759955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006469794,0.00021263908,0.00023923529,0.00014694752,0.000050071325,0.0000058521973,0.00015388042,0.00007322121,0.000019088382],"category_scores_gemma":[0.000017538065,0.00019968636,0.00004583246,0.00008880685,0.00013916598,0.000017943476,0.000096898904,0.00008710138,0.0000019306897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037175526,0.0028711774,0.102748826,0.00069108565,0.00055497396,0.0013105003,0.01601547,0.004691972,0.7947614,0.0023432625,0.0022795466,0.06801423],"study_design_scores_gemma":[0.002908694,0.0007640554,0.14221734,0.00016224575,0.000033989,0.000019330371,0.0025916945,0.0013573936,0.70001066,0.001224027,0.14760543,0.0011051638],"about_ca_topic_score_codex":0.000032474538,"about_ca_topic_score_gemma":0.00020578192,"teacher_disagreement_score":0.14532588,"about_ca_system_score_codex":0.000016594911,"about_ca_system_score_gemma":0.00010733075,"threshold_uncertainty_score":0.8142973},"labels":[],"label_agreement":null},{"id":"W1759449679","doi":"10.4137/dti.s1146","title":"A Model for NAD(P)H: Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy","year":2009,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation; Welch Foundation","keywords":"Cancer research; Chemotherapy; Benzoquinone; NAD+ kinase; Medicine; Bone marrow; Pharmacology; Chemistry; Enzyme; Biochemistry; Immunology; Internal medicine","score_opus":0.12457566101711524,"score_gpt":0.43092028224312057,"score_spread":0.3063446212260053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1759449679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98101366,0.004087419,0.0025868795,0.0050927117,0.0017540543,0.0014085062,0.0007487994,0.00028911248,0.0030188493],"genre_scores_gemma":[0.9753218,0.000558758,0.0060240957,0.013383751,0.0005731324,0.00020110178,0.00030023485,0.000050027586,0.003587096],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782723,0.00018364398,0.00044588526,0.00060008717,0.00023332817,0.0007098198],"domain_scores_gemma":[0.9988465,0.00011413062,0.00022227666,0.00027433372,0.00019725229,0.00034552044],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029047494,0.00043752725,0.00050021417,0.00018241252,0.0005181223,0.00005111868,0.00044937033,0.00031384107,0.0009170782],"category_scores_gemma":[0.000028105243,0.00038577398,0.00025472377,0.00027846976,0.00015873631,0.0002468562,0.00003941568,0.0004964525,0.000039570314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042850045,0.0042533297,0.0025256735,0.0001638984,0.0012838043,0.00010094208,0.020917576,0.006058399,0.4528198,0.016648479,0.46334,0.027603095],"study_design_scores_gemma":[0.009051431,0.0001962849,0.0013213917,0.000036102727,0.00020969112,0.00001041713,0.00017179301,0.19443654,0.22041017,0.025834842,0.54725903,0.00106231],"about_ca_topic_score_codex":0.000026769518,"about_ca_topic_score_gemma":0.000030232028,"teacher_disagreement_score":0.23240963,"about_ca_system_score_codex":0.000114308605,"about_ca_system_score_gemma":0.00021377907,"threshold_uncertainty_score":0.99999624},"labels":[],"label_agreement":null},{"id":"W2277636392","doi":"10.4137/dti.s9442","title":"Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent","year":2012,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Resveratrol; Neuroinflammation; Angiogenesis; Matrix metalloproteinase; Inflammation; Cancer research; Gene silencing; Pharmacology; Blood–brain barrier; Medicine; Chemistry; Biology; Immunology; Central nervous system; Internal medicine; Biochemistry; Gene","score_opus":0.011675455683288547,"score_gpt":0.24532722704263693,"score_spread":0.2336517713593484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277636392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98789775,0.0048714136,0.00010009781,0.0015067672,0.00082724995,0.00073144253,0.000021976388,0.000066600966,0.003976696],"genre_scores_gemma":[0.9953458,0.00016351102,0.0013039883,0.0008049007,0.0014763002,0.000022969878,0.00008583825,0.000054793083,0.0007419046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99740064,0.00018721593,0.00070300495,0.00039570645,0.0007491889,0.00056425476],"domain_scores_gemma":[0.99841803,0.00021806039,0.00030809426,0.00039738553,0.00021203309,0.00044639743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074347766,0.00035033276,0.00061830564,0.0003456786,0.00018159991,0.000021732445,0.00012485587,0.00022648655,0.0002600555],"category_scores_gemma":[0.00020308576,0.00026446025,0.00016218789,0.00027730345,0.00012016869,0.00025658312,0.00008057414,0.00037597993,0.00003139673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004183392,0.00020336591,0.031233383,0.00031010655,0.00020237052,0.000048337588,0.010118198,0.0000049947275,0.9473037,0.00018724699,0.009092781,0.00087717193],"study_design_scores_gemma":[0.005563694,0.00035078527,0.013858885,0.00015452191,0.00021275993,0.000055624205,0.0018831476,0.0010396433,0.94987154,0.000116304924,0.026527915,0.00036518255],"about_ca_topic_score_codex":0.00021983562,"about_ca_topic_score_gemma":0.000010377388,"teacher_disagreement_score":0.017435135,"about_ca_system_score_codex":0.0000922764,"about_ca_system_score_gemma":0.00013544729,"threshold_uncertainty_score":0.99998075},"labels":[],"label_agreement":null},{"id":"W3215818202","doi":"10.33393/dti.2021.2347","title":"Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury","year":2021,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"European Society of Intensive Care Medicine; Ministero dell’Istruzione, dell’Università e della Ricerca; Società Italiana Anestesia, Analgesia, Rianimazione e Terapia Intensiva","keywords":"Medicine; ARDS; Bronchoalveolar lavage; Lung; Inflammation; Pulmonary fibrosis; Fibrosis; Pulmonary compliance; Pathology; Internal medicine","score_opus":0.006968065066650779,"score_gpt":0.24400300859119448,"score_spread":0.23703494352454368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215818202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942467,0.002550505,0.0010407285,0.0008015228,0.0003587532,0.0003812686,0.000016004275,0.00009032292,0.000514195],"genre_scores_gemma":[0.9932962,0.00040095902,0.0037202912,0.0006027961,0.00018715169,0.000036945068,0.0002356936,0.00004109017,0.001478879],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849296,0.000068746165,0.00044660392,0.00042107524,0.0002780212,0.00029259565],"domain_scores_gemma":[0.99914336,0.000034180244,0.00009137186,0.00034825536,0.0001814383,0.00020141844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016624687,0.00022521461,0.0004075757,0.00022233951,0.00009252178,0.000045327728,0.00007284828,0.00015684788,0.0002911803],"category_scores_gemma":[0.000063420506,0.0002026945,0.000078023106,0.00034345555,0.000019404022,0.00028188457,0.000098311815,0.0002392931,0.000025352372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039211873,0.0002647074,0.023677876,0.00064674264,0.00042267214,0.0018388343,0.008100701,0.00008053335,0.93136436,0.01930668,0.0103324475,0.0035723157],"study_design_scores_gemma":[0.0016481368,0.00009087829,0.0027840754,0.00026272374,0.00014827235,0.000050647992,0.00046259628,0.018102078,0.9309146,0.00901465,0.03612836,0.0003929884],"about_ca_topic_score_codex":0.000019957884,"about_ca_topic_score_gemma":0.00004074961,"teacher_disagreement_score":0.025795912,"about_ca_system_score_codex":0.000077449884,"about_ca_system_score_gemma":0.00018982193,"threshold_uncertainty_score":0.8265642},"labels":[],"label_agreement":null},{"id":"W4252246510","doi":"10.33393/dti.2008.1333","title":"Therapies to Increase ApoA-I and HDL-Cholesterol Levels","year":2008,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Medicine; Cholesterol; Ldl cholesterol; Internal medicine; Bioinformatics; Intensive care medicine; Biology","score_opus":0.019949095845854983,"score_gpt":0.2353904733805925,"score_spread":0.21544137753473752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252246510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98815864,0.0055081923,0.00024180421,0.0007606765,0.00017807542,0.0006659467,0.000015774547,0.0001414245,0.0043294644],"genre_scores_gemma":[0.99100965,0.00024087058,0.0024738875,0.0026697794,0.00046500965,0.00006527589,0.000024812318,0.000047983318,0.0030027279],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998478,0.00010155465,0.0002486183,0.0004163066,0.00042443044,0.00033108992],"domain_scores_gemma":[0.99883497,0.00004629552,0.00004519668,0.0005482034,0.00010738096,0.0004179421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019334683,0.00025677515,0.00054934825,0.00019142225,0.00020168486,0.000031464057,0.000108567074,0.00009102671,0.00009413783],"category_scores_gemma":[0.00008335349,0.00020168531,0.0001869,0.00019803316,0.00012585698,0.00017185579,0.00007330484,0.00019625566,0.00018242968],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001178137,0.0020492482,0.035491064,0.0008413044,0.004336245,0.0030816628,0.12326154,0.00009300251,0.012567514,0.0011854073,0.06811941,0.74779546],"study_design_scores_gemma":[0.0029182532,0.00022748655,0.36759406,0.00013301695,0.00012949792,0.00023174012,0.00034680538,0.00003804545,0.020667732,0.0006658428,0.6065875,0.00045995635],"about_ca_topic_score_codex":0.003049405,"about_ca_topic_score_gemma":0.00024981727,"teacher_disagreement_score":0.7473355,"about_ca_system_score_codex":0.00003532953,"about_ca_system_score_gemma":0.00007304608,"threshold_uncertainty_score":0.82244885},"labels":[],"label_agreement":null},{"id":"W4361197222","doi":"10.33393/dti.2008.1332","title":"Recent Advancements in Targeted Delivery of Therapeutic Molecules in Neurodegenerative Disease–-Spinocerebellar Ataxia–-Opportunities and Challenges","year":2008,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Faculty of Medicine, McGill University; McGill University","keywords":"Medicine; Spinocerebellar ataxia; Disease; Neuroscience; Bioinformatics; Intensive care medicine; Pathology; Psychology; Biology","score_opus":0.048467719500114276,"score_gpt":0.2384463568752153,"score_spread":0.189978637375101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361197222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9068847,0.0916994,0.000078973404,0.00032062683,0.00021631442,0.00021464888,0.000026767138,0.0000070726414,0.0005515213],"genre_scores_gemma":[0.8112026,0.1874543,0.00036511087,0.00041730364,0.000057210316,0.00002926728,0.0001939475,0.000016843076,0.00026343993],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988278,0.0002306394,0.00027878393,0.0003646353,0.000111990346,0.00018612995],"domain_scores_gemma":[0.99952185,0.000014985364,0.00008694184,0.00021771793,0.000074240685,0.00008427262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062492225,0.00017494509,0.00021641469,0.00013055261,0.000049496237,0.0000034508757,0.00009617448,0.0000815137,0.00003606907],"category_scores_gemma":[0.000027881953,0.0001646322,0.000036970232,0.0000838833,0.00012754317,0.000010193269,0.00006528459,0.00008431013,0.0000018085432],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038775948,0.0019055462,0.055749133,0.0004355595,0.0002481268,0.0009983339,0.010621867,0.0028559316,0.8863914,0.005949383,0.0022738024,0.028693343],"study_design_scores_gemma":[0.0037239315,0.00062069134,0.06284358,0.00006410988,0.000027242253,0.000031333035,0.0013586221,0.0006791157,0.3234226,0.0011899499,0.60519385,0.00084493926],"about_ca_topic_score_codex":0.00001570912,"about_ca_topic_score_gemma":0.00017057429,"teacher_disagreement_score":0.60292006,"about_ca_system_score_codex":0.000012202878,"about_ca_system_score_gemma":0.00008845803,"threshold_uncertainty_score":0.67135066},"labels":[],"label_agreement":null},{"id":"W4385283736","doi":"10.33393/dti.2012.1373","title":"Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent","year":2012,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Resveratrol; Medicine; Inflammation; Matrix metalloproteinase; Bioinformatics; Carcinogen; Cancer research; Pharmacology; Neuroscience; Internal medicine; Biology; Genetics","score_opus":0.0077311540817577235,"score_gpt":0.22626720317475676,"score_spread":0.21853604909299904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385283736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928023,0.0051166434,0.00015425557,0.00011083423,0.00031114442,0.00032721512,0.00006375862,0.000018586701,0.001095224],"genre_scores_gemma":[0.99824667,0.00008071643,0.00052355597,0.00019816631,0.0005430807,0.00002122648,0.0002020195,0.000038773334,0.00014577698],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984576,0.00017969374,0.00035455296,0.00036115295,0.0002876236,0.00035935742],"domain_scores_gemma":[0.9990755,0.000039957784,0.00020669562,0.00036943774,0.000108734566,0.00019969116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002834498,0.00023616261,0.00021399335,0.0000984602,0.00011804404,0.00002548918,0.00017741515,0.00016637953,0.00004806836],"category_scores_gemma":[0.00015319379,0.00022945687,0.00013289224,0.000096555705,0.00007071547,0.000023381694,0.0001456627,0.000099166595,0.000011829324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009212711,0.00008176986,0.017337546,0.000069276684,0.000091971895,0.000003923046,0.0010072885,0.0000108690665,0.97810066,0.00006427352,0.002891172,0.000249119],"study_design_scores_gemma":[0.00090169575,0.00005950449,0.004520869,0.000013272811,0.000038524347,0.000006090976,0.00027260144,0.000086977074,0.9770549,0.000093057264,0.016684467,0.00026801563],"about_ca_topic_score_codex":0.00007271144,"about_ca_topic_score_gemma":0.000015866799,"teacher_disagreement_score":0.013793295,"about_ca_system_score_codex":0.00002826984,"about_ca_system_score_gemma":0.000086233864,"threshold_uncertainty_score":0.9356979},"labels":[],"label_agreement":null},{"id":"W4385284415","doi":"10.33393/dti.2009.1337","title":"A Model for NAD(P)H:Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy","year":2009,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation; Welch Foundation","keywords":"Medicine; Chemotherapy; Cancer imaging; Cancer chemotherapy; Oncology; NAD+ kinase; Cancer; Internal medicine; Medical physics; Bioinformatics; Cancer research; Biology; Biochemistry; Enzyme","score_opus":0.1214002722564105,"score_gpt":0.42995407238189937,"score_spread":0.3085538001254889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385284415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98014885,0.0041780397,0.0028094049,0.0052074725,0.0017908314,0.0014689359,0.00076971314,0.00030019053,0.003326551],"genre_scores_gemma":[0.97449815,0.00055903,0.0063874186,0.013555121,0.0005819,0.00020556175,0.0003047749,0.00005092825,0.0038571227],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978075,0.00018163008,0.0004487222,0.00060714275,0.00023558139,0.00071939186],"domain_scores_gemma":[0.99883693,0.000113111346,0.00022344143,0.00027735706,0.00019986209,0.00034926843],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029160135,0.00044260177,0.0005035236,0.00018401326,0.00052464043,0.000051940395,0.00045511755,0.00031837722,0.00096213794],"category_scores_gemma":[0.00002788883,0.0003903439,0.00025734794,0.00028154385,0.00016066438,0.00024737077,0.000040527775,0.00050111243,0.00004061553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004261055,0.0041894745,0.0024274478,0.00016462644,0.001290389,0.0001049806,0.01920116,0.0063560726,0.4458682,0.016568411,0.47053313,0.029035047],"study_design_scores_gemma":[0.008864115,0.00019274857,0.0012665788,0.000035020257,0.00020689462,0.000010435591,0.00015147886,0.19827226,0.22022432,0.025129529,0.54460883,0.0010378064],"about_ca_topic_score_codex":0.000022881868,"about_ca_topic_score_gemma":0.000024645567,"teacher_disagreement_score":0.22564387,"about_ca_system_score_codex":0.0001137743,"about_ca_system_score_gemma":0.0002103738,"threshold_uncertainty_score":0.9999511},"labels":[],"label_agreement":null},{"id":"W4385439599","doi":"10.33393/dti.2013.1346","title":"Impact of Hepatocyte Growth Factor on Skeletal Myoblast Transplantation Late After Myocardial Infarction","year":2013,"lang":"en","type":"article","venue":"Drug Target Insights","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Greenfield Research (Canada); Dalhousie University","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Hepatocyte growth factor; Myocardial infarction; Transplantation; Skeletal muscle; Growth factor; Myocyte; Infarction; Cardiology; Internal medicine; Pathology","score_opus":0.006742084129002327,"score_gpt":0.24695662901004678,"score_spread":0.24021454488104446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385439599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972359,0.000039841965,0.0005421607,0.00016937628,0.0001528216,0.000619159,0.00009985285,0.00013936112,0.0010015308],"genre_scores_gemma":[0.99811065,0.00040085314,0.0006193994,0.00026232534,0.00012619782,0.000053393975,0.00019864482,0.00003405695,0.00019450071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988424,0.00005310504,0.00034797052,0.00023086734,0.00031284784,0.00021280858],"domain_scores_gemma":[0.9993707,0.000050435254,0.000105058105,0.00018000523,0.0001526466,0.00014114256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003713538,0.00022799698,0.00033834626,0.00024841016,0.00004500676,0.000019888152,0.000059126607,0.00011465182,0.00086852605],"category_scores_gemma":[0.000008283473,0.00016391728,0.00030035357,0.0001685573,0.0000490347,0.00028972153,0.0000053063286,0.00019182895,0.00016357648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029627916,0.00083073607,0.886047,0.0014161905,0.0008727539,0.00017591915,0.014257965,0.00006221465,0.08919574,0.0006932941,0.0018915953,0.0015937701],"study_design_scores_gemma":[0.0012426208,0.00046799862,0.8984391,0.00009185563,0.00008564358,0.00001698316,0.000013903184,0.00011792351,0.098825544,0.00040430683,0.000115631316,0.00017845746],"about_ca_topic_score_codex":0.0004324971,"about_ca_topic_score_gemma":0.00000957191,"teacher_disagreement_score":0.014244061,"about_ca_system_score_codex":0.000080297934,"about_ca_system_score_gemma":0.000057930298,"threshold_uncertainty_score":0.9509751},"labels":[],"label_agreement":null}]}